SS
GILD icon

SBI Securities’s Gilead Sciences GILD Stock Holding History

SBI Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.58M Sell
18,492
-1,356
-7% -$190K 0.07% 149
2025
Q4 		$2.44M Sell
19,848
-291
-1% -$35.4K 0.06% 170
2025
Q3 		$2.24M Sell
20,139
-593
-3% -$67.4K 0.06% 181
2025
Q2 		$2.3M Sell
20,732
-477
-2% -$50.8K 0.07% 169
2025
Q1 		$2.38M Sell
21,209
-138
-0.6% -$14.2K 0.08% 142
2024
Q4 		$1.97M Buy
+21,347
New +$1.92M 0.06% 161

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SBI Securities's GILD Position: Q1 2026 in Review

SBI Securities reduced its Gilead Sciences (GILD) stake by 6.8% in Q1 2026, selling an estimated $190K and leaving 18,492 shares worth $2.58M. The position accounts for 0.07% of the portfolio, ranked #149.

SBI Securities first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • SBI Securities held 18,492 shares of Gilead Sciences worth $2.58M as of Q1 2026.
  • SBI Securities sold 1,356 Gilead Sciences shares in Q1 2026, an estimated $190K.
  • Gilead Sciences made up 0.07% of SBI Securities's portfolio in Q1 2026, its #149 holding.
  • SBI Securities first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.